Print this page
-
Quality of Life Outcomes of Transurethral Resection of Bladder Tumor and Intravesical Therapy in Non-Muscle Invasive Bladder Cancer
Protocol: 002450Principal Investigator:
- Vignesh Packiam
Applicable Disease Sites: Urinary Bladder -
A survey of pediatric and adolescent and young adult (AYA) cancer patients primary care providers (PCPs) regarding communication with the oncology team
Protocol: 002549Principal Investigator:
- Dawn Tortajada
Applicable Disease Sites: Any Site -
Wholeness in Healing: Evaluating the Effect of Quality of Life (QOL) on Integrative Therapy Interventions Performed During Outpatient Systemic Therapy Treatment for Women with Stage IIII Breast Cancer- A Pilot Study.
Protocol: 002553Applicable Disease Sites: Breast
-
Prospective Evaluation and Validation of AI-Enhanced Ultrasound Imaging for Early Detection of Liver Disease
Protocol: 002571Applicable Disease Sites: Liver
Other -
RADA16 for Skin Graft Donor Site Wound Healing
Protocol: 002574Applicable Disease Sites: Other Skin
-
A Prospective Registry of Spine Cancer Patients Undergoing Surgical decompression followed by Radiation Therapy for Spine Tumors
Protocol: 002575Principal Investigator:
- Jonathan Sherman
Applicable Disease Sites: Brain and Nervous System -
A mail-based HPV sampling program to increase cervical cancer screening in New
Jersey
Protocol: 002576Principal Investigator:
- Ana Tergas
Applicable Disease Sites: Cervix -
Assessing Collaborations Between Radiation Oncologists and Population
Scientists
Protocol: 002577Applicable Disease Sites: Any Site
-
Real-Time Tracking of Neighborhood Environments and Activity Spaces on Health Behaviors, Perceived Stress and Well-Being among Young Adults with Cancer
Protocol: 002578Principal Investigator:
- Katie Darabos
Applicable Disease Sites: Any Site -
The Prophylactic Use of Loratadine for Granulocyte-Colony Stimulating Factor (G-CSF) Induced Bone Pain in Multiple Myeloma Patients Undergoing Stem Cell Mobilization.
Protocol: 011910Principal Investigator:
- Mansi R Shah
Applicable Disease Sites: Bones and Joints
Ill-Defined Sites
Multiple Myeloma -
Machine Learning-based High-throughput and Integrative Immunological Synapse Quality Evaluation As a Composite Biomarker for Predicting CAR Therapy Efficacy in Immuno-Oncology.
Protocol: 012108Principal Investigator:
- Yun Kyoung Tiger
Applicable Disease Sites: Hodgkin's Lymphoma
Multiple Myeloma
Non-Hodgkin's Lymphoma -
Study Protocol Cancer in Pregnancy (CIP-study)
Protocol: 012201Principal Investigator:
- Andrew Evens
Applicable Disease Sites: Any Site
Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma -
A Long-Term Study for Participants Previously Treated With Ciltacabtagene Autoleucel.
Protocol: 012204Principal Investigator:
- Matthew Matasar
Applicable Disease Sites: Multiple Myeloma -
Open-Label Dose-Finding and Dose-Expansion Study to Evaluate the Safety, Expansion, Persistence, and Clinical Activity of UCART20x22 (in Subjects with Relapsed or Refractory B-Cell Non-Hodgkin s Lymphoma (B-NHL).
Protocol: 012208Principal Investigator:
- Matthew Matasar
Applicable Disease Sites: Non-Hodgkin's Lymphoma -
Antibodies to Commensal Bacteria in Lymphoma Pathogenesis
Protocol: 012209Principal Investigator:
- Yun Kyoung Tiger
Applicable Disease Sites: Non-Hodgkin's Lymphoma -
A Phase 1 Study to Assess Safety and Tolerability of REGN5837, an Anti-CD22 x Anti-CD28 Costimulatory Bispecific Monoclonal Antibody, in Combination with Odronextamab, an Anti-CD20 x Anti-CD3 Bispecific Monoclonal Antibody, in Patients with Aggressive B-Cell Non-Hodgkin Lymphomas (ATHENA-1)
Protocol: 012303Principal Investigator:
- Matthew Matasar
Applicable Disease Sites: Non-Hodgkin's Lymphoma